Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a confirmed diagnosis of one of the following blood cancers: chronic lymphocytic leukaemia (CLL), B-cell or T-cell prolymphocytic leukaemia (B-PLL or T-PLL), small lymphocytic lymphoma (SLL), T-cell or NK-cell large granular lymphocytic leukaemia (T or NK-LGL), hairy cell leukaemia (HCL), or Richter's transformation
- People who are 18 years of age or older
- People who have signed a written consent form agreeing to take part
- People who fall into at least one of the following situations: newly diagnosed and currently being monitored without treatment (a "watch and wait" approach, including within a clinical trial); currently receiving or having previously received standard approved treatments outside of a clinical trial; being assessed to see whether a stem cell transplant might be recommended; or having a disease that has come back after previous treatment (even if first diagnosed before this registry began)
Who may not be able to join:
- People who do not have a confirmed diagnosis of one of the specific blood cancers listed above
- People who have a condition affecting brain function, or who do not have the legal capacity to consent to participation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michael Hallek, MD, German CLL Study Group, Department I of Internal Medicine University Hospital Cologne
Phone: +4922147888220
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.